Cardiogeni (AQSE:CGNI) FCF Yield %: 0.00 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cardiogeni FCF Yield %?

Cardiogeni AQSE:CGNI FCF Yield % is 0.00 as of Sep. 11, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cardiogeni's Trailing 12-Month Free Cash Flow is £0.00 Mil, and Market Cap is £5.97 Mil. Therefore, Cardiogeni's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Cardiogeni's FCF Yield % or its related term are showing as below:


AQSE:CGNI's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.49
* Ranked among companies with meaningful FCF Yield % only.

Cardiogeni's FCF Margin % for the quarter that ended in . 20 was 0.00%.

Cardiogeni FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Cardiogeni FCF Yield % Related Terms

Cardiogeni FCF Yield % Historical Data

* Premium members only.

The historical data trend for Cardiogeni's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiogeni FCF Yield % Chart

Cardiogeni Annual Data
Trend
FCF Yield %

Cardiogeni Semi-Annual Data
FCF Yield %

AQSE:CGNI vs : FCF Yield % Comparison

For the Biotechnology subindustry, Cardiogeni's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardiogeni FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiogeni's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cardiogeni's FCF Yield % falls into.


Cardiogeni FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cardiogeni's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
= /
=N/A%

Cardiogeni's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
= * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Cardiogeni (AQSE:CGNI) has a FCF Yield % of 0.00 as of Sep. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cardiogeni and its competitors.
Is Cardiogeni's FCF Yield % too high?
Cardiogeni's current FCF Yield % is 0.00.
How does Cardiogeni's FCF Yield % compare to ?
Cardiogeni's FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cardiogeni and its competitors. Cardiogeni's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiogeni stock overvalued right now?
Cardiogeni (AQSE:CGNI) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Cardiogeni (AQSE:CGNI), the current FCF Yield % is 0.00 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cardiogeni Business Description

Comparable Companies
Address Celixir House Stratford-Upon-Avon Business & Technology Park, Innovation Way, Stratford upon Avon, GBR, CV37 7GZ
Cardiogeni PLC is engaged in the development and commercialisation of a portfolio of novel cellular medicines for heart failure. The Company focuses on the development and commercialisation of novel cellular medicines targeting early- and mid-stage heart failure. Its strategic priority is to complete a pivotal Phase 2b/3 study and obtain first market approval for its product, CLXR-001, in a suitable jurisdiction, and then establish strategic funding and collaboration agreements to develop and commercialise the product in the US, EU, Japan, and other jurisdictions.